| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
104.63(B) |
| Last
Volume: |
8,786,292 |
Avg
Vol: |
8,469,733 |
| 52
Week Range: |
$48.64 - $73.26 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
| Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
19 |
36 |
69 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Macmillan Stephen P |
Director |
• • – |
2015-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
948 |
948 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2015-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
948 |
948 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
3,464,532 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2015-03-20 |
4 |
AS |
$18.00 |
$630,000 |
D/D |
(35,000) |
87,981 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2015-03-20 |
4 |
OE |
$12.52 |
$438,200 |
D/D |
35,000 |
122,981 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2015-03-20 |
4 |
AS |
$18.00 |
$324,900 |
D/D |
(18,050) |
25,600 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2015-03-20 |
4 |
OE |
$8.30 |
$223,541 |
D/D |
18,050 |
43,650 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2015-03-19 |
4 |
AS |
$17.77 |
$196,964 |
D/D |
(11,085) |
87,981 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2015-03-16 |
4 |
AS |
$17.18 |
$515,634 |
D/D |
(30,022) |
99,066 |
|
- |
|
| Sorenson John Bradley |
SVP, Manuf & Sup Chn |
• • – |
2015-03-13 |
4 |
AS |
$16.84 |
$64,497 |
D/D |
(3,830) |
11,476 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2015-03-09 |
4 |
AS |
$16.54 |
$42,359 |
D/D |
(2,561) |
25,600 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens Health |
• • – |
2015-03-03 |
4 |
AS |
$16.79 |
$41,838 |
D/D |
(2,492) |
17,430 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2015-03-03 |
4 |
AS |
$16.79 |
$214,359 |
D/D |
(12,768) |
129,088 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2015-03-03 |
4 |
AS |
$16.79 |
$150,814 |
D/D |
(8,983) |
28,161 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$44,937 |
D/D |
(2,659) |
90,754 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,911 |
93,413 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$35,794 |
D/D |
(2,118) |
43,584 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,514 |
45,702 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$76,625 |
D/D |
(4,534) |
180,783 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,624 |
185,317 |
|
- |
|
| Bose Supratim |
EVP & President, Asia-Pacific |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,766 |
116,395 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• – – |
2015-02-28 |
4 |
D |
$16.90 |
$109,799 |
D/D |
(6,497) |
141,856 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• – – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,791 |
148,353 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & President, CRM |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$78,044 |
D/D |
(4,618) |
128,254 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & President, CRM |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,580 |
132,872 |
|
- |
|
2009 Records found
|
|
Page 1 of 81 |
|
|
0.09 (0.12%) 
